336 related articles for article (PubMed ID: 10632331)
1. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
[TBL] [Abstract][Full Text] [Related]
2. Sequential immunochemotherapy and edrecolomab in the adjuvant therapy of breast cancer: reduction of 17-1A-positive disseminated tumour cells.
Kirchner EM; Gerhards R; Voigtmann R
Ann Oncol; 2002 Jul; 13(7):1044-8. PubMed ID: 12176782
[TBL] [Abstract][Full Text] [Related]
3. Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease.
Braun S; Hepp F; Sommer HL; Pantel K
Int J Cancer; 1999 Feb; 84(1):1-5. PubMed ID: 9988223
[TBL] [Abstract][Full Text] [Related]
4. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients.
Pierga JY; Deneux L; Bonneton C; Vincent-Salomon A; Nos C; Anract P; Magdelénat H; Pouillart P; Thiery JP
Int J Biol Markers; 2004; 19(1):23-31. PubMed ID: 15077923
[TBL] [Abstract][Full Text] [Related]
6. EpCAM: A new therapeutic target for an old cancer antigen.
Armstrong A; Eck SL
Cancer Biol Ther; 2003; 2(4):320-6. PubMed ID: 14508099
[TBL] [Abstract][Full Text] [Related]
7. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
8. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
Lustberg MB; Balasubramanian P; Miller B; Garcia-Villa A; Deighan C; Wu Y; Carothers S; Berger M; Ramaswamy B; Macrae ER; Wesolowski R; Layman RM; Mrozek E; Pan X; Summers TA; Shapiro CL; Chalmers JJ
Breast Cancer Res; 2014 Mar; 16(2):R23. PubMed ID: 24602188
[TBL] [Abstract][Full Text] [Related]
10. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.
Pantel K; Schlimok G; Angstwurm M; Weckermann D; Schmaus W; Gath H; Passlick B; Izbicki JR; Riethmüller G
J Hematother; 1994; 3(3):165-73. PubMed ID: 7530132
[TBL] [Abstract][Full Text] [Related]
11. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours.
Schlimok G; Pantel K; Loibner H; Fackler-Schwalbe I; Riethmüller G
Eur J Cancer; 1995 Oct; 31A(11):1799-803. PubMed ID: 8541104
[TBL] [Abstract][Full Text] [Related]
12. Drug evaluation: IGN-101--an anti-EpCAM murine antibody vaccine for cancer.
Kirman I
Curr Opin Mol Ther; 2006 Aug; 8(4):358-65. PubMed ID: 16955700
[TBL] [Abstract][Full Text] [Related]
13. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S
Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.
Braun S; Kentenich C; Janni W; Hepp F; de Waal J; Willgeroth F; Sommer H; Pantel K
J Clin Oncol; 2000 Jan; 18(1):80-6. PubMed ID: 10623696
[TBL] [Abstract][Full Text] [Related]
16. Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastases.
Kasimir-Bauer S; Otterbach F; Oberhoff C; Schmid KW; Kimmig R; Seeber S
Int J Mol Med; 2003 Dec; 12(6):969-75. PubMed ID: 14612976
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
18. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
Choesmel V; Pierga JY; Nos C; Vincent-Salomon A; Sigal-Zafrani B; Thiery JP; Blin N
Breast Cancer Res; 2004; 6(5):R556-70. PubMed ID: 15318937
[TBL] [Abstract][Full Text] [Related]
19. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.
Effenberger KE; Borgen E; Eulenburg CZ; Bartkowiak K; Grosser A; Synnestvedt M; Kaaresen R; Brandt B; Nesland JM; Pantel K; Naume B
Breast Cancer Res Treat; 2011 Feb; 125(3):729-38. PubMed ID: 20449649
[TBL] [Abstract][Full Text] [Related]
20. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.
Watson MA; Ylagan LR; Trinkaus KM; Gillanders WE; Naughton MJ; Weilbaecher KN; Fleming TP; Aft RL
Clin Cancer Res; 2007 Sep; 13(17):5001-9. PubMed ID: 17785550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]